Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.3186 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.31206 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.31253 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.24893 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.11863 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.37103 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.30211 | 11 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.33021 | 14 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.29293 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.29746 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.29555 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.29459 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.30184 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.29831 | 12 |